Results 81 to 90 of about 34,432 (188)

Safety and effectiveness of remdesivir for the treatment of COVID-19 patients with end-stage renal disease: A retrospective cohort study

Journal of Microbiology, Immunology and Infection
Background: Remdesivir has been used to treat severe coronavirus 2019 (COVID-19); however, its safety and effectiveness in patients remain unclear. This study aimed to investigate the safety and effectiveness of remdesivir in patients with COVID-19 with ...
Yan-Bo Huang, Chip-Jin Ng, Cheng-Hsun Chiu, Chung-Hsien Chaou, Shi-Ying Gao, Shou-Yen Chen   +5 more
doaj  

Safety and heart rate changes in Covid-19 patients treated with Remdesivir

International Journal of Infectious Diseases, 2021
Objectives: Limited data are available regarding the occurrence and the extent of cardiac rhythm disturbances in patients with COVID-19 treated with Remdesivir.
Natale Daniele Brunetti, MD, PhD, Mariacristina Poliseno, MD, Irene Francesca Bottalico, MD, Antonio Centola, MD, Laura Montemurro, MD, Salvatore Sica, MD, Teresa Santantonio, MD, Sergio Lo Caputo, MD   +7 more
doaj  

Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning‐Based Advanced Perspectives

Advanced Science, Volume 12, Issue 15, April 17, 2025.
Graphic illustration showing the strategic approaches based on the currently investigated evidence of psychedelics that suggests the challenges and how to address the prescription of mental disorders. These applicable avenues may provide substantial insight into distinguishing between brain networks and psychedelics.
Sung‐Hyun Kim, Sumin Yang, Jeehye Jung, Jeonghyeon Choi, Mingon Kang, Jae‐Yeol Joo   +5 more
wiley   +1 more source

Plasmapheresis for Facilitating Readministration of Rituximab After Paradoxical Exacerbation in Pemphigus Vulgaris: A Case Report

Clinical Case Reports, Volume 13, Issue 4, April 2025.
ABSTRACT Rare reports of post‐rituximab exacerbation of pemphigus vulgaris (PV) have been published, with some therapeutic protocols proposed for managing this condition. A 40‐year‐old female with PV experienced an exacerbation of mucocutaneous lesions following rituximab administration.
Mohammad Reza Pourani, Sayyed Mojtaba Nekooghadam, Fatemeh Samadi, Sanaz Soleimani, Fahimeh Abdollahimajd   +4 more
wiley   +1 more source

Missed Opportunities on Emergency Remdesivir Use [PDF]

, 2020
Ameet Sarpatwari, Anna Kaltenboeck, Aaron S. Kesselheim   +2 more
openalex   +1 more source

Broad‐Spectrum Antiviral Activity of the Orally Bioavailable Antiviral ATV014 Against Multiple Coronaviruses

MedComm, Volume 6, Issue 5, May 2025.
Sidi Yang, Kun Li, Qifan Zhou, Xumu Zhang, Deyin Guo   +4 more
wiley   +1 more source

Papaverine Targets STAT Signaling: A Dual‐Action Therapy Option Against SARS‐CoV‐2

Journal of Medical Virology, Volume 97, Issue 4, April 2025.
ABSTRACT Papaverine (PV) has been previously identified as a promising candidate in SARS‐CoV‐2 repurposing screens. In this study, we further investigated both its antiviral and immunomodulatory properties. PV displayed antiviral efficacy against SARS‐CoV‐2 and influenza A viruses H1N1 and H5N1 in single infection as well as in co‐infection.
Philipp Reus, Emma Torbica, Tamara Rothenburger, Marco Bechtel, Joshua Kandler, Sandra Ciesek, Philip Gribbon, Aimo Kannt, Jindrich Cinatl, Denisa Bojkova   +9 more
wiley   +1 more source

Ward‐delivered nasal high‐flow oxygen and non‐invasive ventilation are safe for people with acute respiratory failure: a cohort study

Internal Medicine Journal, Volume 55, Issue 4, Page 645-654, April 2025.
Abstract Background and Aims Ward‐delivered non‐invasive respiratory supports (NIRS) (conventional oxygen therapy (COT), high‐flow nasal oxygen (HFNO), continuous positive airway pressure (CPAP) and non‐invasive ventilation (NIV)), are often used to treat hospitalised patients with acute respiratory failure (ARF) both in high acuity and general wards ...
Catherine Buchan, Yet Hong Khor, Rebecca Disler, Matthew T. Naughton, Natasha Smallwood   +4 more
wiley   +1 more source

Remdesivir Use in the Setting of Severe Renal Impairment: A Theoretical Concern or Real Risk? [PDF]

, 2020
Natasha N. Pettit, Jennifer Pisano, Cynthia T. Nguyen, Alison Lew, Aniruddha Hazra, Renslow Sherer, Kathleen M. Mullane   +6 more
openalex   +1 more source

Plasma proteomic profiles correlate with organ dysfunction in COVID‐19 ARDS

Physiological Reports, Volume 13, Issue 7, April 2025.
Abstract Severe COVID‐19 is often complicated by hypoxemic respiratory failure and acute respiratory distress syndrome (ARDS). Mechanisms governing lung injury and repair in ARDS remain poorly understood. We hypothesized that plasma proteomics may uncover protein biomarkers correlated with COVID‐19 ARDS severity. We analyzed the plasma proteome from 32
Moemen Eltobgy, Brett Klamer, Daniela Farkas, James D. Londino, Joshua A. Englert, Jeffrey C. Horowitz, Rama K. Mallampalli, Guy Brock, Joseph S. Bednash   +8 more
wiley   +1 more source